Identification | |
---|---|
Name | N-cyclopropyl-4-methyl-3-{2-[(2-morpholin-4-ylethyl)amino]quinazolin-6-yl}benzamide |
Accession Number | DB08351 |
Type | small molecule |
Description | Not Available |
Structure |
|
Categories (*) | |
Molecular Weight | 431.5301 |
Groups | experimental |
Monoisotopic Weight | 431.232125197 |
Pharmacology | |
Indication | Not Available |
Mechanism of action | Not Available |
Absorption | Not Available |
Protein binding | Not Available |
Biotransformation | Not Available |
Route of elimination | Not Available |
Toxicity | Not Available |
Affected organisms | Not Available |
Interactions | |
Drug Interactions | Not Available |
Food Interactions | Not Available |
Mitogen-activated protein kinase 14 | |
---|---|
Name | Mitogen-activated protein kinase 14 |
Gene Name | MAPK14 |
Pharmacological action | unknown |
Actions | Not Available |
References |
|
DTHybrid score | 1.92 |
Id | Partner name | Gene Name | Score |
---|---|---|---|
1176 | Mitogen-activated protein kinase 1 | MAPK1 | 0.0419 |
3060 | Leukotriene A-4 hydrolase | LTA4H | 0.0209 |
933 | Proto-oncogene tyrosine-protein kinase Src | SRC | 0.0173 |